RB

Ritu Bhojwani

Director Director DIN 06688448
DIN 06688448 First appointment Jun 2013 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jun 2013
Shareholding value Locked Premium profile

About Ritu Bhojwani

Data last updated:

Ritu Bhojwani has 13 years in corporate governance. Formerly with 1 company, such as Ur Bio Medical Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06688448
Primary Designation Director
First Appointment 20 Jun 2013
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Ur Bio Medical Private Limited U85100HR2010PTC041419
Director20 Jun 20132010Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ur Bio Medical Private Limited
Premium access

Shareholding and investment profile for Ritu Bhojwani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritu Bhojwani

Ritu Bhojwani has 13 years in corporate governance. Formerly with 1 company, such as Ur Bio Medical Private Limited. Engaged in General Business. Contributes to corporate operations.

Ritu Bhojwani is associated with 0 companies as a director.

Ritu Bhojwani has expertise in General Business.

Ritu Bhojwani has 13 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available